Transgenic mice in amyloid research: An interpretive review

Amyloid

Volumn 3, Issue 3, 1996, Pages 187-208

  Teng, Mei Hui ^b   Buxbaum, Joel N ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

Alzheimer's disease; Amyloid beta protein; Familial amyloidotic polyneuropathy; Islet amyloid polypeptide; Neurodegenerative diseases; Targeted gene disruption (gene knock out); Transgenic; Transthyretin

Indexed keywords

EID: 1842432531     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506129609045521     Document Type: Review

References (175)

1. Cohen AS (1992). History of amyloidosis. J Intern Med 232, 509-510
2. Jacobson DR, Gorevic PD and Buxbaum JN (1990). A homozygous transthyretin variant associated with senile systemic amyloidosis: evidence for a late-onset disease of genetic etiology. Am J Hum Genet 47, 127-136
3. Hamilton JA, Steinrauf LK, Braden BC, Liepnieks J, Benson MD, Holmgren G, Sandgren O and Steen L (1993). The X-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30→Met variant to 1.7-Å resolution. J Biol Chem 268, 2416-2424
4. Steinrauf LK, Hamilton JA, Braden BC, Murrell JR and Benson MD (1993). X-ray crystal structure of the Ala-109→Thr variant of human transthyretin which produces euthyroid hyperthyroxinemia. J Biol Chem 268, 2425-2430
5. Hamilton JA, Steinrauf LK, Liepnieks J, Benson MD, Holmgren G, Sandgren O and Steen L (1992). Alteration in molecular structure which results in disease: The Met-30 variant of human plasma transthyretin. Biochim Biophys Acta Mol Basis Dis 1139, 9-16
6. Steinrauf LK, Cao Y, Hamilton J, Murrell J, Liepnieks JJ and Benson MD (1991). Preparation and crystallization of human transthyretin (prealbumin) variants. Biochem Biophys Res Commun 179, 804-809
7. Blake CCF, Geisow MJ and Oatley SJ (1978). Structure of prealbumin: secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 Å. J Mol Biol 121, 339-356
8. Damas AM, Sehastiao MP, Ribeiro S, Palha J and Saraiva MJ: Structural alterations in Ile122 and Pro55 variant TTRs: their importance in amyloid formation. 3rd International Symposium on Familial Amyloidotic Polyneuropathy and oilier Transthyretin Related Disorders, Lisboa, Portugal, October 27-29, 1995, Program & Abstracts O1, 1995 (abstr.)
9. Terry CJ and Blake CCF (1992). Comparison of the modelled thyroxine binding site in TBG with the experimentally determined site in transthyretin. Protein Eng 5, 505-510
10. Terry CJ, Damas AM, Oliveira P, Saraiva MJM, Alves IL, Costa PP, Matias PM, Sakaki Y and Blake CCF (1993). Structure of Met30 variant of transthyretin and its amyloidogenic implications. EMBO J 12, 735-741
11. Gustavsson Å, Engström U and Westermark P (1991). Normal transthyretin and synthetic transthyretin fragments form amyloid-like fibrils in vitro. Biochem Biophys Res Commun 175, 1159-1164
12. Gassett M, Baldwin MA, Lloyd DN, Gabriel J-M, Holtzman DM, Cohen F, Fleiterick R and Prusiner SB (1992). Predicted α-helical region of the prion protein when synthesized as peptides form amyloid. Proc Natl Acad Sci USA 89, 10940-10944
13. Maury CPJ and Nurmiaho-Lassila E-L (1992). Creation of amyloid fibrils from mutant ASN187 gelsolin peptides. Biochem Biophys Res Commun 183, 227-231
14. Westermark GT, Engström U and Westemark P (1992). The N-terminal segment of protein AA determines its fibrillogenic property. Biochem Biophys Res Commun 182, 27-33
15. Gorevic PD, Castano EM, Sarma R and Frangione B (1987). Ten to fourteen residue peptides of Alzheimer's disease fibril formation and its characteristic Xray diffraction pattern. Biochem Biophys Res Commun 147, 854-862
16. Jarrett JT and Lansbury PT, Jr. (1993). Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie. Cell 73, 1055-1058
17. Sipe JD (1992). Amyloidosis. Ann Rev Biochem 61, 947-975
18. Johnson KH, O'Brien TD, Betsholtz C and Westermark P (1989). Islet amyloid, islet amyloid polypeptide, and diabetes mellitus. N Engl J Med 321, 513-518
19. Sletten K, Westermark P and Natvig JB (1976). Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid. J Exp Med 143, 993-998
20. Sletten K and Westennark P: Characterization of molecular forms of calcitonin in amyloid fibrils from medullary carcinoma of the thyroid. Amyloid and Amyloidosis 1990 113, 1990 (abstr.)
21. Looi LM (1993). Isolated atrial amyloidosis: a clinicopathologic study indicating increased prevalence in chronic heart disease. Hum Path 24, 602-607.
22. Johansson B and Westermark P: Isolated Atrial Amyloidosis. Increased frequency in patients with congestive heart failure, in Natvig JB, Forre O, Husby G, Husebekk A, Skogen B, Sletten K, Westennark P (eds): Amyloid and Amyloidosis 1990, Kluwer Academic, Dordrecht, Boston, London, 1991, p 474
23. Johansson B and Westermark P (1990). The relation of atrial natriuretic factor to isolated atrial amyloid. Exp Mol Pathol 52, 266-278
24. 2-microglobulin. Biochem Biophys Res Commun 129, 701-706.
25. Glenner GG (1980). Amyloid deposits and amyloidosis. The β-fibrilloses (first of two parts). N Engl J Med 302, 1283-1292
26. Glenner GG (1980). Amyloid deposits and amyloidosis. The β-fibrilloses (second of two parts). N Engl J Med 302, 1333-1343
27. Buxbaum J (1992). Mechanisms of disease: Monoclonal immunoglobulin deposition. Amyloidosis, light chain deposition disease, and light and heavy chain deposition disease. Hematal Oncol Clin N Am 6, 323-346
28. Schechter AN and Noguchi CT: Sickle hemoglobin polymer: structure-function correlates, in Embury SH, I Iehhel RP, Mohanda N, Steinberg MH (eds): Sickle Cell Disease: Basic Principles and Clinical Practice, Raven Press, New York, 1994, p 33
29. Ferrone FA: Oxygen transits and transports, in Embury SH, Heppel RP, Mohandas N and Steinberg MH (eds): Sickle Cell Disease: Basic Principles and Clinical Practice, Raven Press, New York , 1994, p 89
30. van Duijn CM, de Knijff P, Cruts M, Wehnert A, Havekes LM, Hofman A and Van Broeckhoven C (1994). Apolipoprotein E4 allele in a population based study of early onset Alzheimer's Disease. Nature Genet 7, 74-78
31. Kisilevsky R, Gruys E and Shirahama T (1995). Does amyloid enhancing factor (AEF) exist? Is AEF a single biological entity? Amyloid:Int J Exp Clin Invest 2, 128-133
32. Kelly JW and Lansbury PT Jr (1994). A chemical approach to elucidate the mechanism of transthyretin and beta-protein amyloid fibril formation. Amyloid:Int J Exp Clin Invest 1, 186-205
33. Jaenisch R and Mintz B (1974). Simian virus 40 DNA sequences in DNA of healthy adult mice derived from preimplantation blastocysts injected with viral DNA. Proc Natl Acad Sci USA 71, 1250-1254
34. Gordon JW, Scangos GA, Plotkin DJ, Barbosa JA and Ruddle FH (1980). Genetic transformation of mouse embryos by microinjection of purified DNA. Proc Natl Acad Sci USA 77, 7380-7384
35. Palmiter RD, Norstedt G, Gehnas RE, Hammer RE and Brinster RL (1983). Metallothionein-human GH fusion genes stimulate growth of mice. Science 222, 809-814
36. Palmiter RD and Brinster RL (1986). Germline transformation of mice. Ann Rev Genet 20, 465-499
37. Merlino GT (1991). Transgenic animals in biomedical research. FASEB J 5, 2996-3001
38. Hanahan D (1996). Transgenic mice as probes into complex systems. Science 246, 1265-1275
39. Thomas KR and Capecchi MR (1987). Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51, 503-512
40. Koretsky A (1992). Investigation of cell physiology in the animal using transgenic technology. Am J Physiol 262, C261-C275
41. Eva A (1992). Use of transgenic mice in the study of proto-oncogene function. Sem Cell Biol 3, 137-145
42. Iglesias A (1991). Analysis of the immune system with transgenic animals; B-cell development and lymphokines. Experientia 47, 878-884
43. Bluethmann H (1991). Analysis of the immune system with transgenic animals:T-cell development. Experientia 47, 884-890
44. Kopchick JJ and Chen WY: Transgenic animals as a tool in endocrinology; structure/function studies of peptide hormones employing transgenic mice, in de Pablo F, Scanes CG (eds): Handhook of Endocrine Research and Treatment, Academic Press, New York, 1993, p 515
45. Provost GS, Kretz PL, Hamer RT, Matthews CD, Rogers BJ, Lundberg KS, Dycaico MJ and Short JM (1993). Transgenic system for in vivo mutation analysis. Mutat Res 288, 133-149
46. Episkopou V, Maeda S, Nishiguchi S, Shimada K, Gaitanaris GA, Gottesman ME and Rohertson EJ (1993). Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone. Proc Natl Acad Sci USA 90, 2375-2379
47. Wei S, Episkopou V, Piantedosi R, Maeda S, Shimada K, Gottesman ME and Blauer WS (1995). Studies on the metabolism of retinol and retinol-hinding protein in transthyretin-deficient mice produced by homologous recombination. J Biol Chem 270, 866-870
48. Palha JA, Episkopou V, Shimada K, Gottesman ME and Saraiva MJM (1994). Thyroid hormone metabolism in a transtliyretin-null mouse strain. J Biol Chem 269, 33135-33139
49. Wight DC and Wagner TE (1994). Transgenic mice: a decade of progress in technology and research. Mutat Res 307, 429-440
50. Hogan B, Constantini F and Lacy E (1986). Manipulating the mouse embryo. A laboratory manual. New York, Cold Spring Harbor Laboratory
51. Chada K, Magram J, Lacy E and Constantini F (1985). Specific expression of a foreign β-globin gene in erythroid cells of transgenic mice. Nature 314, 377-380
52. Townes TM, Lingrel JB, Chen HY, Brinster RL and Palmiter RD (1985). Erythroid-specific expression of human β globulin in transgenic mice. EMBO J 4, 1715-1723
53. Brinster RL, Allen JM, Behringer RR, Gelinas RE and Palmiter RD (1988). Introns increase transcriptional efficiency in transgenic mice. Proc Natl Acad Sci USA 85, 836-840
54. McKnight RA, Shamay A, Sankaran L, Wall RJ and Henninghausen L (1992). Matrix-attachment regions can impart position-independent regulation of a tissue-specific gene in transgenic mice. Proc Natl Acad Sci USA 89, 6943-6947
55. Stief A, Winter DM, Stratling WM and Sippel AE (1989). A nuclear DNA attachment element mediates elevated and position independent gene activity. Nature 341, 343-345
56. Townes TM, Lingrel JB, Chen HY, Brinster RL and Palmiter RD (1985). Erythroid-specitic expression of human β globulin genes in transgenic mice. EMBO J 4, 1715-1723
57. Bonifer C, Vidal M, Grosveld F and Sippel AE (1990). Tissue specific and position independent expression of the complete gene domain for chicken lysozyme in transgenic mice. EMBO 79, 2843-2848
58. Swain JL, Stewart TL and Leder P (1987). Parental legacy determines methylation and expression of an autosomal transgene: a molecular mechanism for parental imprinting. Cell 50, 719-727
59. Reik W: Genome imprinting, in Grosveld F and Kollias G (eds): Transgenic Animals, Academic Press, San Diego, 1992, p 99
60. Chaillet JR (1994). Genomic imprinting: lessons from mouse transgenes. Mut Res 307, 441-449
61. Byrne GW and Ruddle FH (1989). Multiplex gene regulation: A two-tiered approach to transgene regulation in transgenic mice. Proc Natl Acad Sci USA 86, 5473-5477
62. Koh GY, Klug MG and Field LJ (1993). Atrial natriuretic factor and transgenic mice. Hypertension 22, 634-639
63. Walsh A, Ito Y and Breslow JL (1989). High levels of human Apolipoprotein A-I in transgenic mice result in increased plasma levels of small high density lipoproteins (HDL) particles comparable to human HDL3. J Biol Chem, 264 6488-6494
64. Kievits F, Ivanyi P, Krimpenfort P, Berns A and Ploegh HL (1987). HLA-restricted recognition of viral antigens in HLA transgenic mice. Nature 329, 447-449
65. Storb U (1987). Immunoglobulin transgenes. Ann Rev Immunol 5, 151-174
66. Ferguson RN, Edelhoch H, Saroff HA, Robbins J and Cahnmann HJ (1975). Negative cooperativity in the binding of thyroxine to human serum prealbumin. Biochem 14, 282-289
67. Van Jaarsveld PP, Edelhoch H, Goodman DS and Robbins J (1973). The interaction of human plasma retinol-binding protein with prealbumin. J Biol Chem 248, 4698-4705
68. Gonzalez G and Offord RE (1971). The subunit structure of prealbumin. Biochem J 125, 309-317
69. Kato M, Soprano DR, Makover A, Kato K, Herbert H and Goodman DS (1986). Localization of immunoreactive transthyretin (prealbumin) and of transthyretin mRNA in fetal and adult rat brain. Differentiation 31, 228-235
70. Marione RL, Herbert J, Dwork A and Schon EA (1988). Transthyretin is synthesized in the mammalian eye. Biochem Biophys Res Commun 151, 905-912
71. Herbert J, Wilcox JN, Pham KC, Fremeau RT, Zaviani M, Dwork A, Soprano D, Makover A, Goodman DS, Zimmerman EZ, Roberts JL and Schon EA (1986). Transthyretin: a choroid plexus-specific transport protein in human brain. Neurol 36, 900-911
72. Tu G, Cole T, Duan W and Schreiber G (1989). The nucleotide sequence of transthyretin cDNA isolated from a sheep choroid plexus cDNA. Nucl Acids Res 17, 6384
73. Harms PJ, Tu G-F, Richardson SJ, Aldred AR, Jaworowski A and Schreiber G (1991) Transthyretin (prealbumin) gene expression in choroid plexus is strongly conserved during evolution of vertebrates. Comp Biochem Physiol 99B, 239-249
74. Chanoine J-P, Alex S, Fang SL, Stone S, Leonard JL, Körhle J and Braverman LE (1992). Role of transthyretin in the transport of thyroxine from the blood to the choroid plexus, the cerebrospinal fluid, and the brain. Endocrinol 130, 933-938
75. Wallace MR, Naylor SL, Kluve-Beckemian B, Long GL , McDonald L, Shows TB and Benson MD (1985). Localization of the human prealbumin gene to chromosome 18. Biochem Biophys Res Commun 129, 753-758
76. Whitehead AS, Skinner M, Bruns GAP, Costello W, Edge MD, Cohen AS and Sipe JD (1984). Cloning of human prealbumin complementary DNA. Localization of the gene to chromosome 18 and detection of a variant prealbumin allele in a family with familial amyloid polyneuropathy. Mol Biol Med 2, 411-423
77. Qiu H, Shimada K and Cheng Z (1992). Chromosomal localization of the mouse prealbumin gene (Ttr) by in situ hybridization. Cytogenet Cell Genet 61, 186-188
78. Tsuzuki T, Mita S, Maeda S, Araki S and Shimada K (1985). Structure of the human prealbumin gene. J Biol Chem 260, 12224-12227
79. Yan C, Costa RH, Darnell JE, Jr., Chen J and Van Dyke TA (1990). Distinct positive and negative elements control the limited hepatocyte and choroid plexus expression of transthyretin in transgenic mice. EMBO J 9, 869-878
80. Fung WP, Thomas T, Dickson PW, Aldred AR, Milland J, Dziadek M, Power B, Hudson P and Schreiber G (1988). Structure and expression of the rat transthyretin (prealhumin) gene. J Biol Chem 263, 480-488
81. Wakasugi S, Maeda S, Shimada K, Nakashima H and Migita S (1985). Structural comparisons between mouse and human prealbumin. J Biochem 98, 1707-1714
82. Duan W, Achen MG, Richardson SJ, Lawrence MC, Wettenhall REH, Jaworowski A and Schreiber G (1991). Isolation, characterization, cDNA cloning and gene expression of an avian transthyretin - Implications for the evolution of structure and function of transthyretin in vertebrates. Eur J Biochem 200, 679-687
83. Saraiva MJM: Transthyretin mutations in health and disease. Hum Mutation 5, 191-196
84. Tawara S, Nakazato M, Kangawa K, Matsuo H and Araki S (1995). Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun 116, 880-888
85. Saraiva MJM, Birken S, Costa PP and Goodman DS (1984). Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type: definition of molecular abnormality in transthyretin (prealbumin). J Clin Invest 74, 104-119
86. Saraiva MJM, Costa PP and Goodman DS (1985). Biochemical marker in familial amyloidotic polyneruopathy, Portuguese type. Family studies on the transthyretin (prealbumin)-methionine-30 variant. J Clin Invest 76, 2171-2177
87. Dwulet FE and Benson MD (1984). Primary structure of an amyloid prealbumin and its plasma precursor in a heredofamilial polyneuropathy of Swedish origin. Proc Natl Acad Sci USA 81, 694-698
88. Sasaki H, Tone S, Nakazato M, Yoshioka K, Matsuo H, Kato Y and Sakaki Y (1986). Generation of transgenic mice producing a human transthyretin variant: a possible mouse model for familial amyloidotic polyneuropathy. Biochem Biophys Res Commun 139, 794-799
89. Sasaki H, Nakazato M, Saraiva MJM, Matsuo H and Sakaki Y (1989). Activity of a metallothionein-transthyretin fusion gene in transgenic mice. Possible effect of plasmid sequences on tissue-specific expression. Mol Biol Med 6, 345-353
90. Shimada K, Maeda S, Murakaini T, Nishiguchi S, Tashiro F, Yi S, Wakasugi S, Takahashi K and Yamaimira K (1989). Transgenic mouse model of familial amyloidotic polyneuropathy. Mol Biol Med 6, 333-343
91. Yi S, Takahashi K, Naito M, Tashiro F, Wakasugi S, Mauda S, Shimada K, Yamamura K and Araki S (1991). Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met30) gene: Pathologic similarity to human familial amyloidotic polyneuropathy, type I. Am J Pathol 138, 403-412
92. Araki S, Yi S, Murakami T, Watanabe S, Ikegawa S, Takahashi K and Yamamura K (1994). Systemic Amyloidosis in transgenic mice carrying the mutant human transthyretin (Met 30) gene. Molec Neurobiol 8, 15-23
93. Yokoi K, Ito S, Mabuchi T, Miyakawa K, Palha JA, Iijima H, Tsukahara S, Blaner WS, Saraiva MJM, Gottesman ME, Takahashi K, Yamamura K, Shimada K and Maeda S: A mouse model of Familial Amyloidotic Polyneuropathy type I homozygous for the mutant transthyretin gene. Proc III Int Symp FAP and other TTR related disorders 32, 1995. (abstr.)
94. Ando Y, Tanaka Y, Ueyama H, Sakashita N, Yonehara T, Higuchi K and Araki S (1993). Low plasma apolipoprotein AII levels in human and mouse amyloidosis with mutant transthyretin (Met-30) gene. Ann Neurol 33, 101-103
95. Murakami T, Yi S, Maeda S, Tashiro F, Yamannira K, Takahashi K, Shimada K and Araki S (1992). Effect of serum amyloid P component level on transthyretin-derived amyloid deposition in a transgenic mouse model of familial amyloidotic polyneuropathy. Am J Pathol 141, 451-456
96. Tashiro F, Yi S, Wakasugi S, Maeda S, Shimada K and Yamamura K (1991). Role of serum amyloid P component for systemic amyloidosis in transgenic mice carrying human mutant transthyretin gene. Gerontol 37, S56-S62
97. Ohuchi K, Matsuda A, Maeda S, Shimada K and Miyakawa T (1991). A transgenic mouse line developed to express human amyloidogenic transthyretin cDNA in the brain. Biochem Internat 23, 809-817
98. Costa RH, Grayson DR and Darnell JE (1989). Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and al-antitrypsin genes. Molec Cell Biol 9, 1415-1425
99. Teng M, Gallo G and Buxbaum J: Is an amyloidogenic substrate enough? Transgenic mice producing human TTR Pro55 do not develop amyloid. Proc III Int Symp FAP and Other TTR Disorders O13, 1995 (ahstr.)
100. Waits RP, Uemichi T, Zeldenrust SR, Hull MT, Field L and Benson MD: Development of lines of transgenic mice expressing the human transthyretin Ser 84 variant. Proc III Int Symp FAP and other TTR related disorders 31, 1995 (abstr.)
101. Maeda S, Gottesman M, Constantini F, Blauer WS, Saraiva MJ, Takahashi K, Yamamura K and Shimada K: Use of mouse models to analyse the molecular hases of Familial Amyloidotic Polyneuropathy Type 1. Proc III Int Symp FAP and other TTR related disorders L2, 1995 (abstr.)
102. Watson ML, Rao JK, Gilkeson GS, Ruiz P, Eicher EM, Pisetsky DS, Matsuzawa A, Rochelle JM and Seldin MF (1992). Genetic Analysis of MRL-lpr Mice: Relationship of the Fas Apoptosis Gene to Disease Manifestations and Renal Disease-modifying Loci. J Exp Med 176, 1645-1656
103. Dwulet FE and Benson MD (1983). Polymorphism of human plasma thyroxine binding prealbumin. Biochem Biophys Res Commun 114, 657-662
104. Coelho T: Variability of clinical expression in familial amyloid polyneuropathy. 3rd International Symposium on Familial Amyloidotic Polyneuropathy and other Transthyretin Related Disorders, Lisboa, Portugal, October 27-29, 1995, Program & Abstracts L3, 1995 (abstr.)
105. Evans DA, Funkenstain HH, Albert MS, Scherr PA, Cook NR, Chown MJ, Hebert LE, Hennekens CH and Taylor JO (1989). Prevalence of Alzheimer's disease in a community population of older persons: higher than previously reported. JAMA 262, 2551-2556
106. Mann DM and Esiri MM (1989). The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. Neurol Sci 89, 169-179
107. Glenner GG and Wong CW (1984). Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 122, 1131-1135
108. Rumble B, Retallack R, Hilbich C, Simms G, Multhaup G, Martins R, Hockey A, Montgomery P, Beyreuther K and Masters CL (1989). Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med 320, 1446-1452
109. Masters CL, Simms G, Weimnan NA, Multhamp G, McDonald BL and Beyreuther K (1985). Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA 82, 4245-4249
110. Kang J, Lemaire H, Unterbeck A, Salbaum JM, Masters CL, Grzeschik K, Multhaup G, Beyreuther K and Muller-Hill B (1987). The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733-736
111. Yoshikai S, Sasaki H, Doh-ura K, Furuya H and Sakaki Y (1987). Genomic organization of the human amyloid β-protein precursor gene. Gene 87, 257-263
112. Müller-Hill B and Beyreuther K (1990). Molecular biology of Alzheimer's disease. Ann Rev Biochem 58, 287-307
113. Ponte P, Gonzales-DeWhitt P, Schilling, J, Hsu D, Greenberg B, Davis K, Wallace W, Lieberberg I, Fuller F and Cordell B (1988). A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature 331, 525-527
114. Esch FS, Keim PS, Beattie E, Blacher RW, Culwell AR, Oltersdorf T, McClure D and Ward PJ (1990). Cleavage of amyloid β-peptide during constitutive processing of its precursor. Science 248, 1122-1124
115. Chartier-Harlin M-C, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, Goate A, Rossor M, Roques P, Hardy J and Mullan M (1991). Early-onset Alzheimer's disease caused by mutations at codon 717 of llie β-amyluid precursor protein gene. Nature 353, 844-846
116. Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, Van Duinen SG, Bots GTAM, Luyendijk W and Frangione B (1990). Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248, 1124-1126
117. van Duijn CM, Hendriks L, Cruts M, Hardy JA, Hofman A and Van Broeckhoven C (1991). Amyloid precursor protein gene mutation in early-onset Alzheimer's disease. Lancet 337, 978
118. Naruse S, Igarashi S, Aoki K, Kaneko K, Ihara K, Miyatake T, Kobayashi H, Imizuka T, Shimizu T, Kojima T and Tsuji S (1991). Mis-sense mutation val-ile in exon-17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease. Lancet 337, 978-979
119. Murrell J, Farlow M, Ghetti B and Benson MD (1991). A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science 254, 97-99
120. Tanzi RE, Vaula G, Romano DM, Mortilla M, Huang TL, Tupler RG, Wasco W, Hyman BT, Haines JL, Jenkins BJ, Kalaitsidaki M, Warren AC, McInnis MC, Antonarakis SE, Karlinsky H, Percy ME, Connor L, Growdon J, Crapper-Mclachlan DR, Gusella JF and St George-Hyslop PH (1992). Assessment of amyloid β-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases. Am J Hum Genet 51, 273-282
121. Fidani L and Goate A (1992). Mutations in APP and their role in β-amyloid deposition. Prog Clin Biol Res 379, 145-214
122. Schellenherg GD, Bird TD, Wijsman EM, Orr HT, Anderson L, Nemens K, White JA, Bonnycastle L, Weber JL, Alonho E, Potter H, Meston LL and Martin GM (1992). Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science 258, 668-671
123. Levy-Lahad E, Wijsman EM, Nemens E, Anderson L, Goddard KAB, Weher JL, Bird TD and Schellenberg GD (1995). A familial Alzheimer's disease locus on chromosome 1. Science 269, 970-973
124. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Petlingell WM, Yu C, Jondro PD, Schmidt SD, Wang K, Crowley AC, Fu Y, Guenette SY, Galas D, Nemens E, Wijsman EM, Bird TD, Schellenherg GD and Tanzi RE (1995). Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269, 973-977
125. Dewji NN and Singer SJ (1996). Genetic clues to Alzheimer's Disease. Science 271, 159-160
126. Wirak DO, Bayney R, Remabhadran TV, Fracasso RP, Hart JT, Hauer PE, Hsiau P, Pekar SK, Scangos GA, Trapp BD and Unterbeck AJ (1991). Deposits of amyloid β protein in the central nervous system of transgenic mice. Science 253, 323-326
127. Quon D, Wang Y, Catalano R, Scardina JM, Murakami K and Cordell B (1991). Formation of β-umyloid protein deposits in brains of transgenic mice. Nature 352, 239-241
128. Mucke L, Masliah E, Johnson WB, Ruppe MD, Alford M, Rockenstein EM, Forss-Petter S, Pietropaola M and Abraham CR (1994). Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice. Brain Res 666, 151-157
129. Jucker M, Walker LC, Martin LJ, Kitt CA, Kleinman HK, Ingram DK and Price DL (1992). Age-associated inclusions in normal and transgenic mouse brain. Science 255, 1443-1445
130. Kawahata S, Higgins GA and Gordon JW (1991). Amyloid plaques, neurofibrillary tangles and neuronal loss in brains of transgenic mice overexpressing a C-terminal fragment of human amyloid precursor protein. Nature 354, 476-478
131. Kawahata S, Higgins GA and Gordon JW (1992). Alzheimer's retraction. Nature 356, 23
132. Lamb BT, Sisodia SS, Lawler AM, Skint HH, Kitt CA, Kearns WG, Pearson PL, Price DL and Gearhart JD (1993). Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice. Nature Genet 5, 22-29
133. Buxbaum JD, Christensen JL, Ruefli AA, Greengard P and Loring JF (1993). Expression of APP in brains of transgenic mice containing the entire human APP gene. Biochem Biophys Res Commun 197, 639-645
134. Pearson BE and Choi TK (1993). Expression of the human β-amyloid precursor protein gene from a yeast artificial chromosome in transgenic mice. Proc Natl Acad Sci USA 90, 10578-10582
135. Araki E, Yamada T, Takemura K, Yamaguchi H, Sakimura K, Goto I and Sakaki Y (1995). Transgenic mice expressing the amyloid h protein-containing carboxy-terminal fragment of the Alzheimer amyloid precursor protein. Amyloid:Int J Exp Clin Invest 2, 100-106
136. Yamaguchi F, Richards S-J, Beyreuther K, Salbaum M, Carlson GA and Dunnett SB (1991). Transgenic mice for the amyloid precursor protein 695 isoform have impaired spatial memory. NeuroReport 2, 781-784
137. Sandhu FA, Salim M and Zain SB (1991). Expression of the human β-amyloid protein of Alzheimer's disease specifically in the brains of transgenic mice. J Biol Chem 266, 21331-21334
138. Kammesheidt A, Boyce FM, Spanoyannis AF, Cummings BJ, Ortegon M, Cotman C, Vaught JL and Neve RL (1992). Deposition of β/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain. Proc Natl Acad Sci USA 89, 10857-10861
139. Rowland DS, Savage MJ, Huntress FA, Wallace RE, Schwartz DA, Loh T, Melloni RH Jr, Degennaro LJ, Greenburg BD, Siman R, Swanson ME and Scott RW (1995). Mutant and Native Human β-Amyloid precursor proteins in transgenic mouse brain. Neurobiol Aging 16, 685-699
140. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B and Zhao J (1995). Alzheimer-type neuropathology in transgenic mice overproducing V717F Beta-amyloid precursor protein. Nature 373, 523-527
141. LaFerla FM, Tinkle BT, Bieberich CJ, Haudenschild CC and Jay G (1995). The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nature Genet 9, 21-30
142. Alper T, Cramp WA, Haig DA and Clarke MC (1967). Does the agent of scrapie replicate without nucleic acid. Nature 214, 764-766
143. Prusiner SB, McKinley MP, Bowman KA, Bolton DC, Bendheim PE, Groth DF and Glenner GG (1983). Scrapie prions aggregate to form amyloid-like birefrigent rods. Cell 35, 349-358
144. Prusiner SB (1982). Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144
145. Sparkes RS, Simon M, Cohn VH, Fournier REK, Lem J, Klisak I, Heinzmann C, Blatt C, Lucero M, Mohandas T, DeArmond SJ, Westaway D, Prusiner SB and Weiner LP (1986). Assignment of the human and mouse prion protein genes to homologous chromosomes. Proc Natl Acad Sci USA 83, 7358-7362
146. Carlson GA, Ebeling C, Torchia M, Westaway D and Prusiner SB (1993). Delimiting the location of the scrapie prion incubation time gene on chromosome 2 of the mouse. Genetics 133, 979-988
147. Basler K, Oesch B, Scott M, Westaway D, Walchli M, Groth DF, McKinley MP, Prusiner SB and Weissman C (1976). Scrapie and Cellular PrP isoforms are encoded by the same chromosomal gene. Cell 46, 417-428
148. Goldfarb LG, Mitrova E, Brown P, Toh BH and Gajdusek DC (1990). Mutation in codon 200 of scrapie amyloid protein gene in two clusters of Creutzfeldt-Jakob disease in Slovakia. Lancet 336, 514-515
149. Goldfarb LG, Haltia M, Brown P, Nieto A, Kovanen J, McCombie WR, Trapp S and Gajdusek DC (1991). New mutation in scrapie amyloid precursor gene (at codon 178) in Finnish Creutzfeldt-Jakoh kindred. Lancet 337, 425
150. Hsiao K, Meiner Z, Kahana E, Cass C, Kahana I, Avrahami D, Scarlato G, Abranisky O, Prusiner SB and Gabison R (1991). Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease. N Engl J Med 124, 1091-1097
151. Doh-ura K, Tateishi J, Sasaki H, Kitamoto T and Sakaki Y (1989). Pro-Leu change at position 102 of prion protein is the most common hut not the sole mutation related to Gerstmann-Sträussler syndrome. Biochem Biophys Res Commun 163, 974-979
152. Owen F, Poulter M, Lofthouse R, Collinge J, Crow TJ, Risby D, Baker HF, Ridley RM, Hsiao K and Prusiner SB (1989). Insertion in prion protein gene in familial Creutzfeldt-Jakob disease. Lancet 1, 51-52
153. Brown P, Goldfarb LG, Cathala F, Vrbovská A, Sulima M, Nieto A, Gibbs CJ, Jr. and Gajdusek DC (1991). The molecular genetics of familial Creutzfeldt-Jakob disease in France. J Neurol Sci 105, 240-246
154. Goldfarb LG, Brown P, McComhie WR, Goldgaher D, Swergold GD, Wills PR, Cervenakova L, Baron H, Gibbs CJ, Jr. and Gajdusek DC (1991). Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc Natl Acad Sci USA 88, 10926-10930
155. Medori R, Tritschler H-J, LeBlanc A, Villare F, Manetto V, Chen HY, Xue R, Leal S, Montagna P, Cortelli P, Tinuper P, Avoni P, Mochi M, Banizzi A, Hauw JJ, Ott J, Lugaresi E, Autilio-Gambetti L and Gambetti P (1992). Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med 326, 444-449
156. Goldfarb LG, Brown P, Vrbovská A, Baron M, McCombie WR, Cathala F, Gibbs CJ, Jr. and Gajdusek DC (1992). An insert mutation in the chromosome 20 amyloid precursor gene in a Gerstmann-Sträussler-Scheinker family. J Neurol Sci 111, 189-194
157. Scott M, Foster D, Mirenda C, Serban D, Coufal F, Walchli M, Torchia M, Groth D, Carlson G, DeArmond SJ, Westaway D and Prusiner SB (1989). Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell 59, 847-857
158. Scott M, Groth D, Foster D, Torchia M, Yang S-L, DeArmond SJ and Prusiner SB (1993). Propagation of prions with artificial properties in transgenic mice expressing chimeric PrP genes. Cell 73, 979-988
159. Westaway D, DeAnnond SJ, Cayetano-Canlas J, Groth D, Foster D, Yang S-L, Torchia M, Carlson GA and Prusiner SB (1994). Degeneration of skeletal muscle, peripheral nerves, and the central nervous system in transgenic mice overexpressing wild-type prion proteins. Cell 76, 117-129
160. Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp H-P, DeArmond SJ, Prusiner SB, Aguet M and Weissmann C (1992). Normal development and behavior of mice lacking the neuronal cell-surface PrP protein. Nature 356, 577-582
161. Bueler H, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M and Weissmann C (1993). Mice devoid of PrP are resistant to scrapie. Cell 73, 1339-1347
162. Sailer A, Bueler H, Fischer M, Aguzzi A and Weissmann C (1994). No propagation of prions in mice devoid of PrP. Cell 77, 967-968
163. Collinge J, Whittington MA, Sidle KCL, Smith CJ, Palmer MS, Clarke AR and Jefferys JGR (1994). Prion protein is necessary for normal synaptic function. Nature 370, 295-297
164. Whittington MA, Sidle KCL, Gowland I, Meads J, Hill AF, Palmer MS, Jeffries JGR and Collinge J ( 1995). Rescue of neurophysiological phenotype seen in PrP null mice by transgene encoding human prion protein. Nature Genet 9, 197-201
165. Collinge J, Palmer MS, Sidle KCL, Hill AF, Gowland I, Meads J, Asante E, Bradley R, Doey LJ and Lantos PL (1995). Unaltered susceptibility to BSE in transgenic mice expressing human prion protein. Nature 378, 779-783
166. Ganowiak K, Hultinan P, Engstrom U, Gustavsson A and Westermark P (1994). Fibrils from synthetic amyloid-related peptides enhance development of experimental AA amyloidosis in mice. Biochem Biophys Res Commun 199, 306-312
167. Fox N, Schrementi J, Nishi M, Ohagi S, Chan SJ, Heisserman JA, Westermark GT, Leckstrom A, Westennark P and Steiner DF (1993). Human islet amyloid polypeptide transgenic mice as a model of non-insulin-dependent diabetes mellitus (NIDDM). FEBS Lett 323, 40-44
168. Hoppener JWM, Verbeek JS, deKoning EJP, Oosterwijk C, van Hulst KL, Visser-Vernooy HJ, Hofhuis FMA, van Gaalen S, Berends MJH, Hackeng WHL, Jansz HS, Morris JF, Clark A, Capel PJA and Lips CJM (1993). Chronic over-production of islet amyloid polypeptide/amylin intransgenic mice: lysosomal localization of human islet amyloid polypeptide and lack of marked hyperglycemia or hyperinsulinaemia. Diabetologia 36, 1258-1265
169. de Koning EJP, Hoppener JWM, Verbeek JS, Oosterwijk C, van Hulst KL, Baker CA, Lips CJM, Morris JF and Clark A (1994). Human islet amyloid polypeptide accumulates at similar sites in islets of transgenic mice and humans. Diabetes 43, 640-644
170. Clark A, de Koning EJP and Morris JF (1993). Formation of islet amyloid from islet amyloid polypeptide. Biochem Soc Trans 21, 169-173
171. Skinner M, Shirahama T, Benson MD and Cohen AS (1977). Murine amyloid protein AA in casein induced experimental amyloidosis. Lab Invest 36, 420-427.
172. Higuchi K, Naiki H, Kitigawa KI, Hosokawa M and Takeda T (1991). Mouse senile amyloidosis. Virchows Archiv B Cell Pathol 60, 231-238
173. Lipman RD, Gaillard ET, Harrison DE and Bronson RT (1993). Husbandry factors and the prevalence of age-related amyloidosis in mice. Lab Anim Sci 43, 439-444
174. McAdain KPWJ and Sipe JD (1976). Murine model for human secondary amyloidosis: genetic variability of the acute phase serum protein SAA response to endotoxin and casein. J Exp Med 144, 1121-1127
175. Takaoka Y, Suzuki M, Miyakawa K, Yamanura K and Sakaki Y (1996). Transgenic study for a role of Cys-10 in amyloidosis of Met-30 TTR. Neuromusc Disord 6, 531(abstract)